These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 8275488
1. Loss of heterozygosity and p53 gene mutations in breast cancer. Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS. Cancer Res; 1994 Jan 15; 54(2):499-505. PubMed ID: 8275488 [Abstract] [Full Text] [Related]
2. Detection of 17p loss in gastric carcinoma using polymerase chain reaction. Kim CJ, Kim WH, Kim CW, Lee JB, Lee CK, Kim YL. Lab Invest; 1995 Feb 15; 72(2):232-6. PubMed ID: 7853854 [Abstract] [Full Text] [Related]
3. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Bhargava V, Thor A, Deng G, Ljung BM, Moore DH, Waldman F, Benz C, Goodson W, Mayall B, Chew K. Mod Pathol; 1994 Apr 15; 7(3):361-8. PubMed ID: 8058709 [Abstract] [Full Text] [Related]
4. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152 [Abstract] [Full Text] [Related]
5. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Okamoto A, Sameshima Y, Yamada Y, Teshima S, Terashima Y, Terada M, Yokota J. Cancer Res; 1991 Oct 15; 51(20):5632-5. PubMed ID: 1913680 [Abstract] [Full Text] [Related]
6. Mutations in the p53 gene in primary human breast cancers. Osborne RJ, Merlo GR, Mitsudomi T, Venesio T, Liscia DS, Cappa AP, Chiba I, Takahashi T, Nau MM, Callahan R. Cancer Res; 1991 Nov 15; 51(22):6194-8. PubMed ID: 1682043 [Abstract] [Full Text] [Related]
7. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V, Ingvarsson S. Br J Cancer; 1999 Dec 15; 81(7):1103-10. PubMed ID: 10584868 [Abstract] [Full Text] [Related]
8. p53 mutations and histological type of invasive breast carcinoma. Marchetti A, Buttitta F, Pellegrini S, Campani D, Diella F, Cecchetti D, Callahan R, Bistocchi M. Cancer Res; 1993 Oct 01; 53(19):4665-9. PubMed ID: 8402644 [Abstract] [Full Text] [Related]
9. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Cancer Res; 1993 Jul 01; 53(13):3092-7. PubMed ID: 8319216 [Abstract] [Full Text] [Related]
10. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP. Chen YH, Li CD, Yap EP, McGee JO. J Pathol; 1995 Oct 01; 177(2):129-34. PubMed ID: 7490678 [Abstract] [Full Text] [Related]
11. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Nakai H, Misawa S, Toguchida J, Yandell DW, Ishizaki K. Cancer Res; 1992 Dec 01; 52(23):6588-93. PubMed ID: 1423304 [Abstract] [Full Text] [Related]
12. The role of p53 mutations in bilateral breast carcinoma. Ackerman J, Baunoch DA, Gimotty P, George J, Lane MA, Dawson PJ. Mod Pathol; 1995 Apr 01; 8(3):244-8. PubMed ID: 7617647 [Abstract] [Full Text] [Related]
13. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS. Anticancer Res; 1996 Apr 01; 16(4A):2009-15. PubMed ID: 8712735 [Abstract] [Full Text] [Related]
15. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H. Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413 [Abstract] [Full Text] [Related]